Patents by Inventor Lothar Eggeling

Lothar Eggeling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11875298
    Abstract: An NADP(H) nanosensor has i) a nucleic acid sequence to which a regulator is capable of binding, wherein the oxidation state of the regulator depends on the NADP(H) availability; ii) a promoter sequence following the nucleic acid sequence i), to which an RNA polymerase is capable of binding, wherein the affinity of the RNA polymerase for the promoter sequence is influenced by the oxidation state of the regulator; iii) a nucleic acid sequence which is under the control of the promoter sequence ii) and which codes for an autofluorescent protein. The present invention also relates to a cell, a method for isolating genes which code for NADP(H)-dependent enzymes, and the use of an NADP(H) nanosensor.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: January 16, 2024
    Assignee: Forschungszentrum Julich GMBH
    Inventors: Solvej Siedler, Georg Schendzielorz, Stephan Binder, Lothar Eggeling, Stephanie Bringer-Meyer, Michael Bott
  • Publication number: 20230297924
    Abstract: The present invention relates to an NADP(H) nanosensor comprising i) a nucleic acid sequence to which a regulator is capable of binding, wherein the oxidation state of the regulator depends on the NADP(H) availability; ii) a promoter sequence following the nucleic acid sequence i), to which an RNA polymerase is capable of binding, wherein the affinity of the RNA polymerase for the promoter sequence is influenced by the oxidation state of the regulator; iii) a nucleic acid sequence which is under the control of the promoter sequence ii) and which codes for an autofluorescent protein. The present invention also relates to a cell, a method for isolating genes which code for NADP(H)-dependent enzymes, and the use of an NADP(H) nanosensor.
    Type: Application
    Filed: July 22, 2019
    Publication date: September 21, 2023
    Inventors: Solvej SIEDLER, Georg SCHENDZIELORZ, Stephan BINDER, Lothar EGGELING, Stephanie BRINGER-MEYER, Michael BOTT
  • Publication number: 20200027049
    Abstract: The present invention relates to an NADP(H) nanosensor comprising i) a nucleic acid sequence to which a regulator is capable of binding, wherein the oxidation state of the regulator depends on the NADP(H) availability; ii) a promoter sequence following the nucleic acid sequence i), to which an RNA polymerase is capable of binding, wherein the affinity of the RNA polymerase for the promoter sequence is influenced by the oxidation state of the regulator; iii) a nucleic acid sequence which is under the control of the promoter sequence ii) and which codes for an autofluorescent protein. The present invention also relates to a cell, a method for isolating genes which code for NADP(H)-dependent enzymes, and the use of an NADP(H) nanosensor.
    Type: Application
    Filed: July 22, 2019
    Publication date: January 23, 2020
    Inventors: Solvej SIEDLER, Georg SCHENDZIELORZ, Stephan BINDER, Lothar EGGELING, Stephanie BRINGER-MEYER, Michael BOTT
  • Patent number: 10385349
    Abstract: The present invention relates to an NADP(H) nanosensor comprising i) a nucleic acid sequence to which a regulator is capable of binding, wherein the oxidation state of the regulator depends on the NADP(H) availability; ii) a promoter sequence following the nucleic acid sequence i), to which an RNA polymerase is capable of binding, wherein the affinity of the RNA polymerase for the promoter sequence is influenced by the oxidation state of the regulator; iii) a nucleic acid sequence which is under the control of the promoter sequence ii) and which codes for an autofluorescent protein. The present invention also relates to a cell, a method for isolating genes which code for NADP(H)-dependent enzymes, and the use of an NADP(H) nanosensor.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: August 20, 2019
    Assignee: Forschungszentrum Julich GmbH
    Inventors: Solvej Siedler, Georg Schendzielorz, Stephan Binder, Lothar Eggeling, Stephanie Bringer-Meyer, Michael Bott
  • Patent number: 9644226
    Abstract: A method for producing vectors containing a gene coding for an enzyme having reduced or deactivated feedback inhibition and to the use thereof for producing amino acids and nucleotide. Genes coding for feedback-inhibited enzymes are mutagenized in vitro, —ligated into vectors in a further step—the vectors are each transformed in a microorganism containing a metabolite sensor in a further step, which brings about the synthesis of a fluorescent protein at an increased metabolite concentration, —whereupon microorganisms exhibiting increased or maximum fluorescence are selected; and —the vectors that contain a gene coding for an enzyme having reduced or deactivated feedback inhibition are isolated from microorganisms having increased or maximum fluorescence.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: May 9, 2017
    Assignee: Forschungszentrum Juelich GmbH
    Inventors: Georg Schendzielorz, Stephan Binder, Lothar Eggeling, Michael Bott
  • Publication number: 20160298094
    Abstract: A method for identifying a cell having an intracellular concentration of a particular metabolite that is increased compared to the wild type of the cell, wherein the modification of the cell is achieved by recombineering, and to a method for producing a production cell that is genetically modified compared to the wild type of the cell and has optimized production of a particular metabolite, to a method for producing this metabolite, and to nucleic acids suited therefor. A gene coding for a recombinase, which is homologous to a known recombinase gene, is transformed in a cell using a vector, and a DNA containing at least one modified gene G1 to Gn, or at least one mutation M1 to Mn, is inserted into the cell, and the cell that has highest metabolite production is identified by way of metabolite sensors.
    Type: Application
    Filed: November 15, 2013
    Publication date: October 13, 2016
    Inventors: Stephan BINDER, Lothar EGGELING, Michael BOTT
  • Publication number: 20160289776
    Abstract: The present invention relates to a cell which is genetically modified with respect to its wild type and which comprises a gene sequence coding for an autofluorescent protein, wherein the expression of the autofluorescent protein depends on the intracellular concentration of a particular metabolite. The present invention also relates to a method for the identification of a cell having an increased intracellular concentration of a particular metabolite, a method for the production of a cell which is genetically modified with respect to its wild type with optimized production of a particular metabolite, a cell obtained by this method, a method for the production of metabolites and a method for the preparation of a mixture.
    Type: Application
    Filed: May 5, 2016
    Publication date: October 6, 2016
    Inventors: Lothar Eggeling, Michael Bott, Stephan Binder, Julia Frunzke, Nurije Mustafi
  • Patent number: 9234218
    Abstract: The present invention relates to a process for the preparation of methacrylic acid or methacrylic esters, comprising the process steps of IA) preparation of 3-hydroxyisobutyric acid by a process comprising the process step of bringing a cell which has been genetically modified in comparison with its wild type in such a way that it is capable of forming more 3-hydroxyisobutyric acid, or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid in comparison with its wild type, into contact with a nutrient medium comprising, as carbon source, carbohydrates, glycerol, carbon dioxide, methanol, L-valine or L-glutamate under conditions under which 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid are formed from the carbon source, if appropriate, isolation of the 3-hydroxyisobutyric acid from the nutrient medium and also, if appropriate, neutralization of the 3-hydroxyisobutyric acid, IB) dehydration of the 3-hydroxyisobutyric acid with formation of methacrylic acid and also, where
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: January 12, 2016
    Assignee: EVONIK ROEHM GmbH
    Inventors: Achim Marx, Markus Poetter, Stefan Buchholz, Alexander May, Hermann Siegert, Birgit Alber, Georg Fuchs, Lothar Eggeling
  • Publication number: 20150299715
    Abstract: The present invention relates to an NADP(H) nanosensor comprising i) a nucleic acid sequence to which a regulator is capable of binding, wherein the oxidation state of the regulator depends on the NADP(H) availability; ii) a promoter sequence following the nucleic acid sequence i), to which an RNA polymerase is capable of binding, wherein the affinity of the RNA polymerase for the promoter sequence is influenced by the oxidation state of the regulator; iii) a nucleic acid sequence which is under the control of the promoter sequence ii) and which codes for an autofluorescent protein. The present invention also relates to a cell, a method for isolating genes which code for NADP(H)-dependent enzymes, and the use of an NADP(H) nanosensor.
    Type: Application
    Filed: August 16, 2013
    Publication date: October 22, 2015
    Inventors: Solvej Siedler, Georg Schendzielorz, Stephan Binder, Lothar Eggeling, Stephanie Bringer-Meyer, Michael Bott
  • Publication number: 20150284760
    Abstract: A method for producing vectors containing a gene coding for an enzyme having reduced or deactivated feedback inhibition and to the use thereof for producing amino acids and nucleotide. Genes coding for feedback-inhibited enzymes are mutagenized in vitro, —ligated into vectors in a further step—the vectors are each transformed in a microorganism containing a metabolite sensor in a further step, which brings about the synthesis of a fluorescent protein at an increased metabolite concentration, —whereupon microorganisms exhibiting increased or maximum fluorescence are selected; and —the vectors that contain a gene coding for an enzyme having reduced or deactivated feedback inhibition are isolated from microorganisms having increased or maximum fluorescence.
    Type: Application
    Filed: July 23, 2013
    Publication date: October 8, 2015
    Inventors: Georg Schendzielorz, Stephan Binder, Lothar Eggeling, Michael Bott
  • Publication number: 20150218601
    Abstract: The present invention relates to a cell which has been modified in comparison with its wild type in such a way that it is capable of forming more, by comparison with its wild, 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid via methylmalonate-semialdehyde or 3-hydroxybutyryl-coenzyme A as precursors. The invention also relates to a method of generating a genetically modified cell, to the genetically modified cell obtainable by these methods, to a method of producing 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid, to a method of producing methacrylic acid or methacrylic esters, and to a method of producing polymethacrylic acid or polymethacrylic esters. The present invention furthermore relates to an isolated DNA, to a vector, to the use of this vector for transforming a cell, to a transformed cell, and to a polypeptide.
    Type: Application
    Filed: February 18, 2015
    Publication date: August 6, 2015
    Applicant: EVONIK ROEHM GMBH
    Inventors: Achim MARX, Markus Poetter, Stefan Buchholz, Alexander May, Hermann Siegert, Georg Fuchs, Birgit Alber, Lothar Eggeling
  • Publication number: 20130310458
    Abstract: The present invention relates to a cell which is genetically modified with respect to its wild type and which comprises a gene sequence coding for an autofluorescent protein, wherein the expression of the autofluorescent protein depends on the intracellular concentration of a particular metabolite. The present invention also relates to a method for the identification of a cell having an increased intracellular concentration of a particular metabolite, a method for the production of a cell which is genetically modified with respect to its wild type with optimized production of a particular metabolite, a cell obtained by this method, a method for the production of metabolites and a method for the preparation of a mixture.
    Type: Application
    Filed: May 3, 2011
    Publication date: November 21, 2013
    Inventors: Lothar Eggeling, Michael Bott, Stephan Binder, Julia Frunzke, Nurije Mustafi
  • Patent number: 8158390
    Abstract: The invention relates to a method for producing L-valine and to a suitable microorganism. The inventive method is characterized by preferably enhancing the transaminase C activity of a coryneform bacterium, especially Corynebacterium glutamicum. The organisms so modified have a yield in L-valine which is 35.8% higher than that of non-modified organisms.
    Type: Grant
    Filed: August 19, 2005
    Date of Patent: April 17, 2012
    Assignee: Forschungszentrum Julich GmbH
    Inventors: Jan Marienhagen, Lothar Eggeling, Hermann Sahm
  • Patent number: 8119374
    Abstract: This invention relates to the nucleotide sequence of coryneform bacteria coding for proteins which are involved in L-serine metabolism with reduced and switched off L-serine dehydratase activity. The invention also relates to microorganisms used in methods for producing L-serine.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: February 21, 2012
    Assignee: Forschungszentrum Julich GmbH
    Inventors: Petra Peters-Wendisch, Roman Netzer, Lothar Eggeling, Hermann Sahm
  • Patent number: 7981640
    Abstract: L-lysine-producing strains of corynebacteria with enhanced lysE gene (lysine export carrier gene), in which strains additional genes chosen from the group comprising the dapA gene (dihydrodipicolinate synthase gene), the lysC gene (aspartate kinase gene), the dapB gene (dihydrodipicolinate reductase gene) and the pyc gene, but especially the dapA gene and the lysC gene (aspartate kinase gene), are enhanced and, in particular, over-expressed, and a process for the preparation of L-lysine.
    Type: Grant
    Filed: October 10, 2008
    Date of Patent: July 19, 2011
    Assignee: Evonik Degussa GmbH
    Inventors: Caroline Kruetzer, Stephan Hans, Mechthild Rieping, Bettina Mockel, Walter Pfefferle, Lothar Eggeling, Sahm Hermann, Miroslav Patek
  • Publication number: 20110039313
    Abstract: The invention relates to recombinant microorganisms in which polynucleotides which code for lysine decarboxylase are enhanced and, using which, cadaverine (1,5-diaminopentane) is produced fermentatively, with the carbon source used preferably being renewable raw materials such as, for example, glucose, sucrose, molasses and the like.
    Type: Application
    Filed: January 10, 2008
    Publication date: February 17, 2011
    Inventors: Stefan Verseck, Harald Haeger, Andreas Karau, Lothar Eggeling, Hermann Sahm
  • Publication number: 20100291644
    Abstract: The present invention relates to a process for the preparation of methacrylic acid or methacrylic esters, comprising the process steps of IA) preparation of 3-hydroxyisobutyric acid by a process comprising the process step of bringing a cell which has been genetically modified in comparison with its wild type in such a way that it is capable of forming more 3-hydroxyisobutyric acid, or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid in comparison with its wild type, into contact with a nutrient medium comprising, as carbon source, carbohydrates, glycerol, carbon dioxide, methanol, L-valine or L-glutamate under conditions under which 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid are formed from the carbon source, if appropriate, isolation of the 3-hydroxyisobutyric acid from the nutrient medium and also, if appropriate, neutralization of the 3-hydroxyisobutyric acid, IB) dehydration of the 3-hydroxyisobutyric acid with formation of methacrylic acid and also, where
    Type: Application
    Filed: May 30, 2008
    Publication date: November 18, 2010
    Applicant: Evonik Roehm GmbH
    Inventors: Achim Marx, Markus Poetter, Stefan Buchholz, Alexander May, Hermann Siegert, Birgit Alber, Georg Fuchs, Lothar Eggeling
  • Publication number: 20100261233
    Abstract: L-lysine-producing strains of corynebacteria with enhanced lysE gene (lysine export carrier gene), in which strains additional genes chosen from the group comprising the dapA gene (dihydrodipicolinate synthase gene), the lysC gene (aspartate kinase gene), the dapB gene (dihydrodipicolinate reductase gene) and the pyc gene, but especially the dapA gene and the lysC gene (aspartate kinase gene), are enhanced and, in particular, over-expressed, and to a process for the preparation of L-lysine.
    Type: Application
    Filed: October 10, 2008
    Publication date: October 14, 2010
    Applicant: Evonik Degussa GmbH
    Inventors: Caroline Kreutzer, Stephan Hans, Mechthild Rieping, Bettina Mockel, Walter Pfefferle, Lothar Eggeling, Hermann Sahm, Miroslav Patek
  • Publication number: 20100151449
    Abstract: The invention relates to a method for production of L-amino acids by fermentation. According to the invention, the activity of the alanine transaminase is ether reduced or inhibited, whereby in particular the amino acids L-valine, L-lysine and L-isoleucine are produced with increased yield. Furthermore, the nucleic acids according to seq. No. 1 from position 101 to 1414 are identified as the sequence coding for the alanine transaminase gene. Use of the above permits the production of L-alanine.
    Type: Application
    Filed: April 20, 2006
    Publication date: June 17, 2010
    Inventors: Jan Marinhagen, Lothar Eggeling, Hermann Sahm
  • Patent number: 7732176
    Abstract: The invention relates to nucleotide sequences of coryneform bacteria that encode proteins that are involved in the biosynthesis of L-serine and to a method for producing L-serine. According to the invention, at least 79 amino acids at the C terminus of the wild-type serA sequence are deleted, thereby producing a 3-phosphoglycerate dehydrogenase having a reduced feedback inhibition by L-serine vis-à-vis the wild-type sequence.
    Type: Grant
    Filed: July 8, 2003
    Date of Patent: June 8, 2010
    Assignees: Forschungszentrum Julich GmbH, Amino GmbH
    Inventors: Lothar Eggeling, Petra Peters-Wendisch, Roman Netzer, Hermann Sahm, Robert Faurie, Birgit Klassen